Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

doi:10.4291/wjgp.v6.i4.235

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8391)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

436

WORD

265

HTML

2588

Figures (1-2)

213

Tables (1-5)

211

Sum=3713

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

522

Download

1206

Sum=1728

Publishing Process of This Article

Item

Count

Browse

1200

Download

1750

Sum=2950

Nov 15, 2015 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 235-242
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.235

Table 1 Differences in Kaplan-Meier estimated median survival between individual drugs groups

Drug name	Number taking the drug out of 164 patients	Median survival estimate for those taking the drug (d)	Median survival for those not taking the drug (d)	P value (log rank test)
ACEI/ARB	41	539	611	0.652
CCB	26	815	528	0.061
Aspirin	55	504	546	0.846
Statins	39	504	577	0.368

Significance calculated using log-rank tests. ACEI/ARB: Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers; CCB: Calcium channel blockers.

Citation: Tingle SJ, Moir JA, White SA. Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. World J Gastrointest Pathophysiol 2015; 6(4): 235-242
URL: https://www.wjgnet.com/2150-5330/full/v6/i4/235.htm
DOI: https://dx.doi.org/10.4291/wjgp.v6.i4.235